Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study
Original Research | By EB Engels, B Thibault, FW Prinzen et al.
Original Research | By MH Cao , LL Zhao, B Yu et al.
OBJECTIVES - This study sought to investigate nonculprit plaque characteristics in patients with ST-segment elevation myocardial infarction (STEMI) presenting with plaque erosion (PE) and plaque rupture (PR). Pancoronary vulnerability was considered at nonculprit sites: 1) the CLIMA (Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome) study (NCT02883088) defined high-risk plaques with simulta...
Original Research | By LC Steffes, AA Froistad, ME Kumar et al.
Original Research | By FM Asch, SH Little, GB Mackensen et al.
BACKGROUND - An independent panel of experts reviewed all investigator-reported cases of mitral valve leaflet adverse events (LAE) after MitraClipTM NTR/XTR in the EXPAND Study. AIMS - We aimed to report the findings of the expert panel and standardize definitions for LAE. METHODS - Standard definitions for different types of LAE were fo...
Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation
Original Research | By O Shaihov-Teper, E Ram, N Ballan et al.
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes
Original Research | By D Csengeri, N-A Sprünker, RB Schnabel et al.
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
BACKGROUND - The benefit of optimal medical therapy (OMT) on 5-year outcomes in patients with 3-vessel disease and/or left main disease after percutaneous coronary intervention or coronary artery bypass grafting (CABG) was demonstrated in the randomized SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trial. OBJECTIVES - The objective of this analysis is to assess the impact of t...